Biochem. J., 1984, 219, 345-373; Eur. J. Biochem., 1984, 138, 9-37; Internat. J. Pept. Prot. Res., 1984, 24, following p 84; J. Biol. Chem., 1985, 260, 14-42; Pure Appl. Chem., 1984, 56, 595-624; Amino Acids and Peptides, 1985, 16, 387-410; and in Biochemical Nomenclature and Related Documents, 2nd edition, Portland Press, 1992, pp 39-67.
Contents list for 3AA-17.3. The spelling of skeleton has been corrected.
At the end of paragraph 1 of 3AA-13.4 the pentapeptide has lost the line representing the lactone ring from Thr to Asp. It should be
3AA-13.5 "5-" was omitted from the systematic name of leukotriene D. It is placed in front of hydroxy. (Published with the incorrect spelling of leukotriene).
3AA-15.2.3 The name and abbreviation have been changed to 2-aminopentanoic acid (from 2-aminovaleric acid) and to Ape (from Avl) to be consistant with the table in 3AA-15.2.5.
3AA-15.2.5 Table entry 3 the systematic names have been reversed to reflect the abbreviation used. Hence 2-Aminopentanoic acid (2-aminovaleric acid) instead of 2-Aminovaleric acid (2-aminopentanoic acid).
3AA-19.3 In the example at the end of paragraph 1, the spelling of its has been corrected.
3AA-21.5 paragraph 2, sentence 3. The spelling of connected (from corrected) has been corrected.
3AA-21.5 paragraph 3, last sentence. The spelling of analogy (from analog) has been corrected.
Appendix. The closing bracket in the structure of homoserine has been inserted. i.e. HO-CH2-CH2-CH(NH3+)COO-
Addendum 3. The structure used was not oxytocin but [Arg8]vasopressin. It should have been .